Good Laboratory Practices
Learning Objectives
By the end of this page you should be able to:
- Define GLP and explain why it exists as a formal regulatory concept, not just "being careful"
- Identify the core pillars of GLP: quality assurance, documentation, personnel training, safety, and equipment calibration
- Explain the ALCOA principle and why data integrity is central to GLP
- Distinguish GLP from GMP and GCP and know which stage of drug development each governs
- Apply GLP thinking to a sample analytical workflow, from sample collection to reporting
- Recognize common GLP violations and their consequences
Quick Answer
Good Laboratory Practices (GLP) are a formal set of quality principles governing how non-clinical laboratory studies are planned, performed, monitored, recorded, and reported, so that the resulting data can be trusted by regulators, manufacturers, and ultimately patients. GLP matters because a brilliant experiment with sloppy documentation is scientifically worthless from a regulatory standpoint — if you can't prove exactly how a result was obtained, who obtained it, and under what conditions, the result cannot be used to support a drug's safety or quality claims. GLP turns good science into defensible science by demanding standard operating procedures, calibrated equipment, trained personnel, and an unbroken paper trail (or electronic equivalent) for every test performed.
Core Content
GLP Is About Trustworthy Data, Not Just "Doing Things Carefully"
Students often think of GLP as a vague synonym for "lab safety" or "being organized," but its actual regulatory purpose is narrower: GLP exists to ensure that data generated in a laboratory is reliable, reproducible, and traceable enough to withstand regulatory scrutiny. A result is only as good as the process that produced it — if two analysts get different numbers testing the same sample because one used an uncalibrated pipette or an undocumented shortcut, neither result can be trusted, no matter how "correct" either analyst believes their number to be. GLP addresses this by standardizing how work is done (SOPs), proving it was done that way (documentation), and verifying the tools used were fit for purpose (calibration).
The Core Pillars of GLP
Quality assurance: a dedicated, functionally independent QA unit audits studies against protocols and SOPs, catching deviations before they undermine the whole study. This independence matters — the people generating the data shouldn't be the only ones checking whether the process was followed correctly.
Documentation: every observation, measurement, and deviation must be recorded contemporaneously (at the time it happens) using standardized forms, with proper sample labeling and storage records. If it isn't written down, from a regulatory perspective, it didn't happen.
Personnel training: staff must be trained on the specific SOPs and safety procedures relevant to their tasks, with training documented and refreshed periodically — an untrained analyst following an SOP incorrectly produces the same unreliable data as no SOP at all.
Safety measures: proper handling and disposal of hazardous materials, correct use of personal protective equipment, and well-maintained facilities protect both personnel and the integrity of the samples being tested.
Equipment calibration and maintenance: instruments must be calibrated against certified standards on a defined schedule, with all calibration activity documented; an uncalibrated balance or pH meter can silently shift every result it produces without anyone noticing until the calibration record is checked.
Data Integrity: The ALCOA Principle
At the heart of modern GLP is a data integrity standard often abbreviated ALCOA: data must be Attributable (you can identify who recorded it and when), Legible (readable and permanent, not erased or obscured), Contemporaneous (recorded at the time the work was done, not reconstructed later from memory), Original (the first record, or a verified true copy — not a pre-processed summary that hides the raw data), and Accurate (a true reflection of what actually happened, including deviations, not a "cleaned-up" version). Some frameworks extend this to ALCOA+, adding that data must also be Complete, Consistent, Enduring, and Available. A common GLP failure is "backdating" — filling in a form days later to make it look contemporaneous — which directly violates the "contemporaneous" and "original" principles and is treated as a serious data integrity breach, not a minor paperwork issue.
GLP vs. GMP vs. GCP: Different Stages, Same Underlying Logic
Students frequently conflate GLP with GMP (Good Manufacturing Practice) and GCP (Good Clinical Practice) because all three share the "Good ___ Practice" naming and the same underlying philosophy of standardized, documented, quality-controlled work. The difference is where in the drug's life each applies:
- GLP governs non-clinical (preclinical) laboratory studies — including analytical testing, toxicology, and stability studies — the evidence gathered before or alongside clinical trials.
- GMP governs the actual manufacturing of pharmaceutical products at commercial or clinical-trial scale.
- GCP governs the conduct of clinical trials involving human participants.
A single drug's regulatory dossier will contain evidence generated under all three frameworks at different points, and mixing them up on an exam (e.g., saying GLP governs manufacturing) is a very common, easily avoidable mistake.
A Practical Walkthrough: GLP in an Analytical Testing Workflow
Consider a pharmacy student tasked with analyzing drug samples for impurities using HPLC. GLP shapes every step: samples are collected and labeled following a written SOP, with collection time and handling conditions documented; the HPLC instrument is calibrated against certified reference standards before the run, with calibration results recorded; samples are analyzed in replicate (not just once) to demonstrate reproducibility, under consistent chromatographic conditions; every peak, retention time, and unexpected observation is documented as it's observed, not reconstructed afterward; and the final report presents results alongside the documentation trail that lets someone else verify exactly how those results were obtained. Skipping any one of these steps — using an uncalibrated instrument, failing to document a deviation, or writing up results the next day from memory — breaks the chain of trust GLP is designed to protect.
Key Terms
| Term | Definition | Context/Related |
|---|---|---|
| Good Laboratory Practice (GLP) | A quality framework for non-clinical laboratory studies ensuring reliable, traceable data | Distinct from GMP and GCP |
| Standard Operating Procedure (SOP) | A written, approved procedure describing exactly how a task must be performed | Basis for consistent, repeatable lab work |
| Quality assurance unit | An independent group auditing studies against protocols and SOPs | Separate from the study-performing personnel |
| ALCOA | Attributable, Legible, Contemporaneous, Original, Accurate — core data integrity principles | Extended to ALCOA+ (Complete, Consistent, Enduring, Available) |
| Contemporaneous recording | Documenting an observation at the time it occurs | Violated by "backdating" records |
| Calibration | Verifying/adjusting an instrument against a certified reference standard | Must be scheduled, performed, and documented |
| Deviation | A departure from an approved SOP or protocol during a study | Must be documented and investigated, not ignored |
| GMP | Good Manufacturing Practice; governs commercial-scale drug manufacturing | Different stage from GLP |
| GCP | Good Clinical Practice; governs human clinical trial conduct | Different stage from GLP |
| Data integrity | The completeness, consistency, and accuracy of data throughout its lifecycle | Central concern of modern GLP inspections |
Common Mistakes
Misconception 1: "GLP just means being careful and organized in the lab." Why it's wrong: This framing treats GLP as a vague personal habit rather than a formal, auditable regulatory framework with specific, enforceable requirements (SOPs, calibration records, independent QA, ALCOA data integrity). Correct explanation: GLP is a defined regulatory standard with specific documentation, training, and quality-assurance requirements that can be inspected and cited for non-compliance — it's a system, not a personality trait.
Misconception 2: "GLP, GMP, and GCP are basically interchangeable terms for 'good pharma practice.'" Why it's wrong: Because all three share similar naming and philosophy, students assume they apply everywhere in drug development, but each governs a distinct stage: GLP for non-clinical lab studies, GMP for manufacturing, GCP for clinical trials. Correct explanation: Know which framework applies to which activity — testing a drug sample's purity in a QC lab falls under GLP-like principles (or GMP quality systems in a manufacturing QC lab), while running a Phase III human trial falls under GCP, and producing commercial tablets falls under GMP.
Misconception 3: "As long as the final result is correct, exactly when or how it was documented doesn't matter." Why it's wrong: This misses the entire point of data integrity — regulators can't verify a result is genuinely correct if the documentation trail is incomplete, reconstructed later, or otherwise doesn't meet ALCOA standards; a "correct-looking" result with a broken paper trail is not regulatorily acceptable. Correct explanation: The documentation trail itself is the evidence that a result is trustworthy. Contemporaneous, attributable, original records are what allow a third party (auditor or regulator) to verify a result without having been present when it was generated.
Comparison and Connections
| Framework | Governs | Example Activity |
|---|---|---|
| GLP | Non-clinical laboratory studies | Impurity testing, toxicology studies, stability testing |
| GMP | Manufacturing of pharmaceutical products | Tablet compression, sterile filling, packaging |
| GCP | Clinical trials in human participants | Phase I-III trial conduct and informed consent |
| Concept | Poor Practice | GLP-Compliant Practice |
|---|---|---|
| Recording data | Written up from memory the next day | Recorded contemporaneously as observed |
| Equipment use | Used without checking calibration status | Calibrated against certified standards on schedule, documented |
| Deviation from SOP | Ignored or unrecorded | Documented and investigated |
| Result verification | Single analyst, single run, no independent check | Independent QA audit, replicate analysis where required |
Practice Questions
Recall
- What does the "C" in ALCOA stand for, and why does it matter? Answer guidance: Contemporaneous — data must be recorded at the time it is generated, not reconstructed later, because delayed or "backdated" recording undermines confidence that the record accurately reflects what actually happened.
- Name the three "Good ___ Practice" frameworks and state which stage of drug development each governs. Answer guidance: GLP (non-clinical laboratory studies), GMP (manufacturing), GCP (clinical trials in humans).
Understanding
- Explain why an independent quality assurance unit is a core requirement of GLP rather than just an optional extra check. Answer guidance: If the same people generating the data are the only ones checking whether procedures were followed, conflicts of interest and blind spots can let deviations go unnoticed; an independent QA unit provides an objective check that increases confidence in the data's reliability.
- Why is an uncalibrated instrument considered a serious GLP violation even if the result "looks reasonable"? Answer guidance: An uncalibrated instrument can produce a systematic error that shifts every result it generates in the same direction, and a result "looking reasonable" doesn't prove it's accurate — only a documented calibration against certified standards can establish that the instrument's readings are trustworthy.
Application
- A student analyst forgets to record the temperature during a sample preparation step and, two days later, writes down what they "remember" the temperature was. What GLP principle does this violate, and why is it a problem? Answer guidance: This violates the contemporaneous and original principles of ALCOA — the record isn't made at the time of the event and relies on memory rather than an actual measurement, so it cannot be trusted as an accurate representation of what happened.
- During an HPLC analysis, a QC analyst notices an unexpected extra peak but decides not to mention it in the report because they assume it's insignificant. Evaluate this decision using GLP principles. Answer guidance: This is a GLP violation — all observations, including unexpected ones, must be documented; deciding unilaterally that something is "insignificant" and omitting it undermines the accuracy and completeness required by ALCOA and could hide a genuine analytical or product problem.
Analysis
- Compare the consequences of a GLP violation in a preclinical toxicology study versus a documentation lapse in a routine QC HPLC assay. Are both equally serious? Answer guidance: Both undermine data integrity, but a GLP violation in a toxicology study can compromise safety conclusions used to justify human trials, while a documentation lapse in routine QC primarily affects confidence in a single batch's quality data; both are serious and can trigger regulatory action, but the toxicology violation carries broader downstream risk (potentially affecting drug approval decisions for an entire program).
- A lab manager argues that requiring instrument calibration before every single use is excessive and time-consuming, and proposes calibrating only once a month regardless of usage frequency. Assess this proposal from a GLP standpoint. Answer guidance: Calibration frequency should be based on documented risk assessment, instrument stability, and usage intensity, not arbitrary convenience — reducing calibration frequency without justification risks undetected instrument drift between calibrations, producing unreliable data across potentially many samples; any change to calibration schedule should be justified, validated, and documented, not simply reduced for convenience.
FAQ
Q: Is GLP a legal requirement or just a best-practice recommendation? A: For studies submitted to regulators to support safety or quality claims (such as non-clinical toxicology or certain analytical studies), GLP compliance is a legal/regulatory requirement, not merely a voluntary best practice — non-compliant studies can be rejected outright.
Q: What's the difference between an SOP and a protocol? A: An SOP is a general, reusable procedure for how to perform a specific task correctly every time (e.g., "how to calibrate a pH meter"); a protocol is the specific plan for a particular study (e.g., "this stability study will test these three batches at these five time points").
Q: Why is "backdating" a record considered so serious if the underlying data is genuinely correct? A: Because GLP's trust model depends on the documentation trail itself proving reliability; if records can be created or altered after the fact, there's no way for an auditor to distinguish a genuinely contemporaneous, honest record from a fabricated one, so backdating is treated as a fundamental integrity breach regardless of whether the specific data happens to be accurate.
Q: Does GLP apply to student lab work in a pharmacy program? A: Formal GLP regulations technically apply to studies submitted to regulatory agencies, but pharmacy programs teach GLP principles because the habits (SOPs, documentation, calibration, honesty about deviations) are exactly what students will need to practice once working in a real regulated lab.
Q: Can a study with excellent scientific results still fail a GLP audit? A: Yes — if the documentation, calibration records, or personnel training records are inadequate, the study can be judged unreliable or non-compliant regardless of how good the actual scientific findings appear, because there's no way to verify the findings were obtained the way the report claims.
Quick Revision
- GLP ensures non-clinical laboratory data is reliable, reproducible, and traceable enough for regulatory use.
- Core pillars: quality assurance (independent audit), documentation, personnel training, safety, equipment calibration.
- ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate — the core data integrity principles.
- ALCOA+ adds: Complete, Consistent, Enduring, Available.
- "If it isn't documented, it didn't happen" is the practical summary of GLP documentation requirements.
- GLP governs non-clinical lab studies; GMP governs manufacturing; GCP governs human clinical trials — don't conflate them.
- Backdating records violates the contemporaneous and original principles and is a serious data integrity breach.
- Equipment must be calibrated against certified standards on a documented schedule before it's trusted for results.
- Deviations from SOPs must be documented and investigated, never silently ignored or "judged insignificant" by one person.
- An independent QA unit exists specifically so the people generating data aren't the only ones verifying the process was followed.
Related Topics
Prerequisites
- Analytical Methods and Quality Control (the work GLP governs)
- Basic laboratory safety concepts
Related Topics
- Regulatory Affairs (GLP studies feed regulatory submissions)
- Quality Control (shares the documentation/specification mindset)
Next Topics
- Advanced Analytical Techniques and method validation
- Regulatory Affairs and the drug approval lifecycle
- Data integrity in electronic laboratory systems